Literature DB >> 29948251

Biomarkers for Alzheimer's disease: from pathogenesis to drug development.

Kenji Hashimoto1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29948251     DOI： 10.1007/s00406-018-0912-4

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN： 0940-1334            Impact factor:   5.270


× No keyword cloud information.
  8 in total

Review 1.  Linking lipids to Alzheimer's disease: cholesterol and beyond.

Authors:  Gilbert Di Paolo; Tae-Wan Kim
Journal:  Nat Rev Neurosci       Date:  2011-03-30       Impact factor: 34.870

2.  Increased quinolinic acid in peripheral mononuclear cells in Alzheimer's dementia.

Authors:  Mandy Busse; Vanessa Hettler; Victoria Fischer; Christian Mawrin; Roland Hartig; Henrik Dobrowolny; Bernhard Bogerts; Thomas Frodl; Stefan Busse
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-06       Impact factor: 5.270

3.  Dysfunction of the blood-cerebrospinal fluid-barrier and N-methyl-D-aspartate glutamate receptor antibodies in dementias.

Authors:  Mandy Busse; Ralf Kunschmann; Henrik Dobrowolny; Jessica Hoffmann; Bernhard Bogerts; Johann Steiner; Thomas Frodl; Stefan Busse
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-02-08       Impact factor: 5.270

4.  Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients.

Authors:  Alana C Costa; Helena P G Joaquim; Valéria S Nunes; Daniel S Kerr; Guilherme S Ferreira; Orestes V Forlenza; Wagner F Gattaz; Leda Leme Talib
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-08-31       Impact factor: 5.270

Review 5.  24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases.

Authors:  Valerio Leoni; Claudio Caccia
Journal:  Biochimie       Date:  2012-10-03       Impact factor: 4.079

Review 6.  CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.

Authors:  Bob Olsson; Ronald Lautner; Ulf Andreasson; Annika Öhrfelt; Erik Portelius; Maria Bjerke; Mikko Hölttä; Christoffer Rosén; Caroline Olsson; Gabrielle Strobel; Elizabeth Wu; Kelly Dakin; Max Petzold; Kaj Blennow; Henrik Zetterberg
Journal:  Lancet Neurol       Date:  2016-04-08       Impact factor: 44.182

Review 7.  Anti-NMDA-Receptor Encephalitis: From Bench to Clinic.

Authors:  Arun Venkatesan; Krishma Adatia
Journal:  ACS Chem Neurosci       Date:  2017-11-07       Impact factor: 4.418

8.  Alzheimer's disease drug-development pipeline: few candidates, frequent failures.

Authors:  Jeffrey L Cummings; Travis Morstorf; Kate Zhong
Journal:  Alzheimers Res Ther       Date:  2014-07-03       Impact factor: 6.982
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.